2,243 publications from this institution
This study explores the potential of calcium-rich fly ash from the Ptolemais region in Greece as a partial cement replacement for improving sulfate resistance in cementitious composites. An integrated experimental program, combining mechanical testing, electrochemical corrosion monitoring and microstructural characterization, was designed to capture the progression of material properties over time and their impact on performance. The experimental results proved that, at early ages, incorporation of fly ash led to reductions in compressive, tensile and bond strengths, attributed to delayed pozzolanic reactivity. However, over prolonged curing, secondary reactions consumed portlandite and generated additional calcium silicate hydrate, refining the pore network and reducing permeability. These microstructural improvements were associated with enhanced mechanical performance, improved durability indices and markedly lower reinforcement corrosion rates. Bond tests further revealed a shift from brittle to a more ductile response, offering advantages for repair applications. These findings establish calcium-rich Ptolemais fly ash as a as a sustainable and promising supplementary cementitious material that substantially enhances the long-term durability and sulfate resistance of cementitious systems.
The reliable estimation of the seismic performance of structures requires quantifying the aleatory and epistemic uncertainties of the system parameters. This is efficiently achieved for a case study of a four-story steel moment-resisting frame through several important advances. First, a state-of-the-art numerical model is formed with full spatial parameterization of its strength and plastic deformation properties. Empirical relationships derived from experimental data are used to model the cyclic behavior of steel sections using probabilistically distributed parameters that include intra- and inter-component correlation. Finally, incremental dynamic analysis and Monte Carlo simulation are employed to accurately assess the seismic performance of the model under the influence of uncertainties. Of interest is the extent to which model parameter uncertainties may trigger negative demand-capacity correlation in structural fragility evaluation, where, for example, a lower ductility capacity for a component may decrease the threshold for local failure while at the same time raising the local demand estimate from an uncertainty-aware model. With respect to the examined steel moment-resisting frame and considering three construction quality levels (i.e. very good, average, low) as per FEMA P-58, it is shown that, despite the good agreement of the evaluated structural demands obtained with and without consideration of the model parameter uncertainties for well-designed modern buildings, the potential demand-capacity correlation is likely to give rise to unconservative estimates of fragility for local damage-states, especially in cases where substandard quality control is exercised during construction.
A bstract : Recent advances in the development of three different types of antiviral drugs, the nucleotide and non‐nucleotide analogues acting as reverse transcriptase inhibitors (NRTIs) and the nonpeptidic viral protease inhibitors (PI), and their introduction in the management of patients with AIDS, either alone or in combination, have dramatically improved the clinical course of the disease and prolonged life expectancy in patients with AIDS. The increase in life expectancy in association with the long‐term use of the above antiviral agents, however, have generated novel morbidities and complications. Central among them is the quite common AIDS‐related insulin resistance and lipodystrophy syndrome, which is characterized by a striking phenotype and marked metabolic disturbances. To look for the pathologic causes of this particular syndrome, we focused on one of the HIV‐1 accessory proteins, Vpr, which has multiple functions, such as virion incorporation, nuclear translocation of the HIV‐1 preintegration complex, nucleo‐cytoplasmic shuttling, transcriptional activation, and induction of apoptosis. Vpr may also act like a hormone, which is secreted into the extracellular space and affects the function of distant organs. Vpr functions as a coactivator of the glucocorticoid receptor and potentiates the action of glucocorticoid hormones, thereby inducing tissue glucocorticoid hypersensitivity. Vpr also arrests host cells at the G2/M phase of the cell cycle by interacting with novel 14‐3‐3 proteins. Vpr facilitates the interaction of 14‐3‐3 and its partner protein Cdc25C, which is critical for the transition of G2/M checkpoint in the cell cycle, and suppresses its activity by segregating it into the cytoplasm. The same Vpr protein also suppresses the association of 14‐3‐3 with other partner molecules, the Foxo transcription factors. Since the Foxo proteins function as negative transcription factors for insulin, Vpr may cause resistance of tissues to insulin. Through these two newly identified functions of Vpr, namely, coactivation of glucocorticoid receptor activity and inhibition of insulin effects on Foxo proteins, Vpr may participate in the development of AIDS‐related insulin resistance/lipodystrophy syndrome.
de Bellis, Michael D.; Chrousos, George P.; Dorn, Lorah D.; Burke, Lillian; Helmers, Karin; Kling, Mitchel A.; Trickett, Penelope K.; Putman, Frank W. Author Information
A bstract : Glucocorticoids regulate a variety of biologic processes and exert profound influences on many physiologic functions. Their actions are mediated by the glucocorticoid receptor (GR), which belongs to the nuclear receptor family of ligand‐dependent transcription factors. Alterations in tissue sensitivity to glucocorticoids may manifest as states of resistance or hypersensitivity. Glucocorticoid resistance is a rare, familial or sporadic, condition characterized by generalized, partial target‐tissue resistance to glucocorticoids. Compensatory elevations in circulating adrenocorticotropic hormone (ACTH) concentrations lead to increased production of adrenal steroids with mineralocorticoid and/or androgenic activity and their corresponding clinical manifestations, as well as increased urinary free‐cortisol excretion in the absence of symptomatology suggestive of hypercortisolism. The molecular basis of the condition has been ascribed to mutations in the GR gene, which impair normal glucocorticoid signal transduction, altering tissue sensitivity to glucocorticoids. The present review focuses on the mechanisms of GR action and the clinical manifestations and molecular mechanisms of familial/sporadic glucocorticoid resistance.
[3H](4-Fluorobutyl)propyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amine ([3H]LWH-154), a novel potent radiolabelled analog of the nonpeptide corticotropin-releasing hormone type 1 receptor (CRHR1) selective antagonist, butylethyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amine (antalarmin), was prepared for the development of positron emission tomography radiotracers for CRHR1 and evaluation as a nonpeptide radioligand for use in pharmacological studies. The precursor (4-fluorobutyl)prop-2-enyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amine (6) for tritiation was prepared in two steps from 3 in 76% total yield. Catalytic reduction of unsaturated fluoride 6 using tritium gas and palladium as catalyst gave [3H]LWH-154. After HPLC purification, [3H]LWH-154 of high radiochemical purity was obtained with a specific activity of 69 Ci/mmol. Copyright © 2000 John Wiley & Sons, Ltd.